ANDA 203760, held by Padagis US. Albuterol Sulfate.
As of Nov 16, 2026, ANDA 203760 (Albuterol Sulfate), held by Padagis US, was first approved by FDA on Feb 24, 2020, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 24, 2020 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Albuterol SulfateEQ 0.09MG BASE/INH ยท aerosol, metered;inhalation | Albuterol Sulfate | Rx |
| Sep 29, 2020 | Supplement 2Manufacturing | Approved | None posted |
| Feb 24, 2020 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters